Medifron DBT Co. Ltd (065650) — Long-term Investment Intensity
Medifron DBT Co. Ltd (065650) has a Long-term Investment Intensity of 5.9% as of December 2019. Long-term investments of ₩1.15 Billion represent 5.9% of total assets of ₩19.46 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 065650 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Medifron DBT Co. Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Medifron DBT Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 5.9%, reflecting long-term investments of ₩1.15 Billion against total assets of ₩19.46 Billion KRW. For the complete balance sheet picture, see 065650 asset base.
Annual Long-term Investment Intensity for Medifron DBT Co. Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Medifron DBT Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Medifron DBT Co. Ltd for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 5.9% | ₩1.15 Billion | ₩19.46 Billion | ▲ +1.3 pp |
| 2018 | 4.6% | ₩985.10 Million | ₩21.57 Billion | ▲ +2.5 pp |
| 2017 | 2.1% | ₩546.85 Million | ₩26.24 Billion | ▼ -3.9 pp |
| 2016 | 6.0% | ₩1.67 Billion | ₩27.75 Billion | ▼ -6.4 pp |
| 2015 | 12.4% | ₩3.83 Billion | ₩30.84 Billion | ▲ +12.4 pp |
| 2014 | 0.0% | ₩12.15 Million | ₩26.48 Billion | — |